Rallybio Co. (NASDAQ:RLYB – Get Rating) – Investment analysts at Wedbush raised their Q2 2023 EPS estimates for Rallybio in a report issued on Tuesday, May 9th. Wedbush analyst L. Chico now forecasts that the company will post earnings per share of ($0.52) for the quarter, up from their prior estimate of ($0.57). Wedbush currently […]